Total Visits

Views
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo650

Total Visits Per Month

April 2026May 2026June 2026July 2026August 2026September 2026October 2026
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo26373347523010

File Visits

Views
2021 RAL cancers.pdf238

Top country views

Views
United States197
Germany131
Ireland94
Singapore48
Hong Kong SAR China25
Brazil24
United Kingdom22
Japan13
South Korea10
Vietnam10

Top cities views

Views
Frankfurt am Main123
Dublin94
Ashburn54
Council Bluffs23
Hong Kong21
London15
San Jose14
Singapore12
Social Circle10
Seoul9